1
van Leent, Merlijn W. J., Stevanovic, Jelena, Jansman, Frank G., Beinema, Maarten J., Brouwers, Jacobus R. B. J., Postma, Maarten J.
Veröffentlicht in: van Leent , M W J , Stevanovic , J , Jansman , F G , Beinema , M J , Brouwers , J R B J & Postma , M J 2015 , ' Cost-Effectiveness of Dabigatran Compared to Vitamin-K Antagonists for the Treatment of Deep Venous Thrombosis in the Netherlands Using Real-World Data ' , PLoS ONE , vol. 10 , no. 8 , e0135054 . https://doi.org/10.1371/journal.pone.0135054;
2015
Veröffentlicht in: van Leent , M W J , Stevanovic , J , Jansman , F G , Beinema , M J , Brouwers , J R B J & Postma , M J 2015 , ' Cost-Effectiveness of Dabigatran Compared to Vitamin-K Antagonists for the Treatment of Deep Venous Thrombosis in the Netherlands Using Real-World Data ' , PLoS ONE , vol. 10 , no. 8 , e0135054 . https://doi.org/10.1371/journal.pone.0135054;
2015
2
de Jong, Lisa Aniek, Gout-Zwart, Judith J, van den Bosch, Marina, Koops, Mike, Postma, Maarten J
Veröffentlicht in: de Jong , L A , Gout-Zwart , J J , van den Bosch , M , Koops , M & Postma , M J 2019 , ' Rivaroxaban for non-valvular atrial fibrillation and venous thromboembolism in the Netherlands : a real-world data based cost-effectiveness analysis ' , Journal of Medical Economics , vol. 22 , no. 4 , pp. 306-318 . https://doi.org/10.1080/13696998.2018.1563404;
2019
Veröffentlicht in: de Jong , L A , Gout-Zwart , J J , van den Bosch , M , Koops , M & Postma , M J 2019 , ' Rivaroxaban for non-valvular atrial fibrillation and venous thromboembolism in the Netherlands : a real-world data based cost-effectiveness analysis ' , Journal of Medical Economics , vol. 22 , no. 4 , pp. 306-318 . https://doi.org/10.1080/13696998.2018.1563404;
2019
3
Stevanovic, J., de Jong, L. A., Kappelhoff, B. S., Dvortsin, E. P., Voorhaar, M., Postma, M. J.
Veröffentlicht in: Stevanovic , J , de Jong , L A , Kappelhoff , B S , Dvortsin , E P , Voorhaar , M & Postma , M J 2016 , ' Dabigatran for the Treatment and Secondary Prevention of Venous Thromboembolism; A Cost-Effectiveness Analysis for the Netherlands ' , PLoS ONE , vol. 11 , no. 10 , e0163550 . https://doi.org/10.1371/journal.pone.0163550;
2016
Veröffentlicht in: Stevanovic , J , de Jong , L A , Kappelhoff , B S , Dvortsin , E P , Voorhaar , M & Postma , M J 2016 , ' Dabigatran for the Treatment and Secondary Prevention of Venous Thromboembolism; A Cost-Effectiveness Analysis for the Netherlands ' , PLoS ONE , vol. 11 , no. 10 , e0163550 . https://doi.org/10.1371/journal.pone.0163550;
2016
4
Smits, E., Andreotti, F., Houben, E., Crijns, H.J.G.M., Haas, S., Spentzouris, G., Schink, T., Gini, R., Bartolini, C., Penning-van Beest, F., Herings, R.
Veröffentlicht in: Smits , E , Andreotti , F , Houben , E , Crijns , H J G M , Haas , S , Spentzouris , G , Schink , T , Gini , R , Bartolini , C , Penning-van Beest , F & Herings , R 2022 , ' Adherence and Persistence with Once-Daily vs Twice-Daily Direct Oral Anticoagulants Among Patients with Atrial Fibrillation: Real-World Analyses from the Netherlands, Italy and Germany ' , Drugs-Real World Outcomes , vol. 9 , no. 2 , pp. 199-209 . https://doi.org/10.1007/s40801-021-00289-w;
2022
Veröffentlicht in: Smits , E , Andreotti , F , Houben , E , Crijns , H J G M , Haas , S , Spentzouris , G , Schink , T , Gini , R , Bartolini , C , Penning-van Beest , F & Herings , R 2022 , ' Adherence and Persistence with Once-Daily vs Twice-Daily Direct Oral Anticoagulants Among Patients with Atrial Fibrillation: Real-World Analyses from the Netherlands, Italy and Germany ' , Drugs-Real World Outcomes , vol. 9 , no. 2 , pp. 199-209 . https://doi.org/10.1007/s40801-021-00289-w;
2022
5
6
7
Seelig, Jaap, Hemels, Martin E. W., Xhaet, Olivier, Bongaerts, Maarten C. M., de Wolf, Axel, Groenemeijer, Bjorn E., Heyse, Alex, Hoogslag, Pieter, Voet, Joeri, Herrman, Jean-Paul R., Vervoort, Geert, Hermans, Walter, Wollaert, Bart, Boersma, Lucas V. A., Hermans, Kurt, Lucassen, Andreas, Verstraete, Stefan, Adriaansen, Henk J., Mairesse, Georges H., Terpstra, Willem F., Faes, Dirk, Pieterse, Mathijs, Virdone, Saverio, Verheugt, Freek W. A., Cools, Frank, ten Cate, Hugo
Veröffentlicht in: Seelig , J , Hemels , M E W , Xhaet , O , Bongaerts , M C M , de Wolf , A , Groenemeijer , B E , Heyse , A , Hoogslag , P , Voet , J , Herrman , J-P R , Vervoort , G , Hermans , W , Wollaert , B , Boersma , L V A , Hermans , K , Lucassen , A , Verstraete , S , Adriaansen , H J , Mairesse , G H , Terpstra , W F , Faes , D , Pieterse , M , Virdone , S , Verheugt , F W A , Cools , F , ten Cate , H & GARFIELD-AF Investigators 2020 , ' Impact of different anticoagulation management strategies on outcomes in atrial fibrillation : Dutch and Belgian results from the GARFIELD-AF registry ' , Journal of Thrombosis and Haemostasis , vol. 18 , no. 12 , pp. 3280-3288 . https://doi.org/10.1111/jth.15081;
2020
Veröffentlicht in: Seelig , J , Hemels , M E W , Xhaet , O , Bongaerts , M C M , de Wolf , A , Groenemeijer , B E , Heyse , A , Hoogslag , P , Voet , J , Herrman , J-P R , Vervoort , G , Hermans , W , Wollaert , B , Boersma , L V A , Hermans , K , Lucassen , A , Verstraete , S , Adriaansen , H J , Mairesse , G H , Terpstra , W F , Faes , D , Pieterse , M , Virdone , S , Verheugt , F W A , Cools , F , ten Cate , H & GARFIELD-AF Investigators 2020 , ' Impact of different anticoagulation management strategies on outcomes in atrial fibrillation : Dutch and Belgian results from the GARFIELD-AF registry ' , Journal of Thrombosis and Haemostasis , vol. 18 , no. 12 , pp. 3280-3288 . https://doi.org/10.1111/jth.15081;
2020
8
Pisters, R., van Vugt, S. P. G., Brouwer, M. A., Elvan, A., ten Holt, W. L., Zwart, P. A. G., Kirchhof, P., Crijns, H. J. G. M., Hemels, M. E. W.
Veröffentlicht in: Pisters , R , van Vugt , S P G , Brouwer , M A , Elvan , A , ten Holt , W L , Zwart , P A G , Kirchhof , P , Crijns , H J G M & Hemels , M E W 2017 , ' Real-life use of Rivaroxaban in the Netherlands : data from the Xarelto for Prevention of Stroke in Patients with Atrial Fibrillation (XANTUS) registry ' , Netherlands Heart Journal , vol. 25 , no. 10 , pp. 551-558 . https://doi.org/10.1007/s12471-017-1009-9;
2017
Veröffentlicht in: Pisters , R , van Vugt , S P G , Brouwer , M A , Elvan , A , ten Holt , W L , Zwart , P A G , Kirchhof , P , Crijns , H J G M & Hemels , M E W 2017 , ' Real-life use of Rivaroxaban in the Netherlands : data from the Xarelto for Prevention of Stroke in Patients with Atrial Fibrillation (XANTUS) registry ' , Netherlands Heart Journal , vol. 25 , no. 10 , pp. 551-558 . https://doi.org/10.1007/s12471-017-1009-9;
2017
9
Peeters, M.T.J., Vroman, F., Schreuder, TAHCML, van Oostenbrugge, R.J., Staals, J.
Veröffentlicht in: Peeters , M T J , Vroman , F , Schreuder , TAHCML , van Oostenbrugge , R J & Staals , J 2022 , ' Decrease in incidence of oral anticoagulant-related intracerebral hemorrhage over the past decade in the Netherlands ' , European Stroke Journal , vol. 7 , no. 1 , 23969873211062011 , pp. 20-27 . https://doi.org/10.1177/23969873211062011;
2022
Veröffentlicht in: Peeters , M T J , Vroman , F , Schreuder , TAHCML , van Oostenbrugge , R J & Staals , J 2022 , ' Decrease in incidence of oral anticoagulant-related intracerebral hemorrhage over the past decade in the Netherlands ' , European Stroke Journal , vol. 7 , no. 1 , 23969873211062011 , pp. 20-27 . https://doi.org/10.1177/23969873211062011;
2022
10
de Vries, T.A.C., Hemels, M.E.W., Cools, F., Crijns, H.J.G.M., Yperzeele, L., Vanacker, P., Blankoff, I., Lancellotti, P., Mairesse, G.H., de Veer, A., Arroyo, R.C., Catez, E., de Pauw, M., Vanassche, T., de Asmundis, C., Kirchhof, P., De Caterina, R., de Groot, J.R., ETNA-AF-Europe, P.r.i.n.c.i.p.a.l.
Veröffentlicht in: de Vries , T A C , Hemels , M E W , Cools , F , Crijns , H J G M , Yperzeele , L , Vanacker , P , Blankoff , I , Lancellotti , P , Mairesse , G H , de Veer , A , Arroyo , R C , Catez , E , de Pauw , M , Vanassche , T , de Asmundis , C , Kirchhof , P , De Caterina , R , de Groot , J R , ETNA-AF-Europe , P R I N C I P A L & ETNA-AF-Europe principal investigators from Belgium and the Netherlands 2021 , ' Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and the Netherlands: insights from the ETNA-AF-Europe study ' , Netherlands Heart Journal , vol. 29 , no. 3 , pp. 158-167 . https://doi.org/10.1007/s12471-020-01518-7;
2021
Veröffentlicht in: de Vries , T A C , Hemels , M E W , Cools , F , Crijns , H J G M , Yperzeele , L , Vanacker , P , Blankoff , I , Lancellotti , P , Mairesse , G H , de Veer , A , Arroyo , R C , Catez , E , de Pauw , M , Vanassche , T , de Asmundis , C , Kirchhof , P , De Caterina , R , de Groot , J R , ETNA-AF-Europe , P R I N C I P A L & ETNA-AF-Europe principal investigators from Belgium and the Netherlands 2021 , ' Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and the Netherlands: insights from the ETNA-AF-Europe study ' , Netherlands Heart Journal , vol. 29 , no. 3 , pp. 158-167 . https://doi.org/10.1007/s12471-020-01518-7;
2021